Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial

Pomegranate has been shown to prolong PSA doubling time in early prostate cancer, but no data from a placebo controlled trial has been published yet. The objective of this study was to prospectively evaluate the impact of pomegranate juice in patients with prostate cancer. We conducted a phase IIb,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenner-Liewen, Frank, Liewen, Heike, Cathomas, Richard, Renner, Christoph, Petrausch, Ulf, Sulser, Tullio, Spanaus, Katharina, Seifert, Hans Helge, Strebel, Räto Thomas, Knuth, Alexander, Samaras, Panagiotis, Müntener, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781990/
https://www.ncbi.nlm.nih.gov/pubmed/24069070
http://dx.doi.org/10.7150/jca.7123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781990/
https://www.ncbi.nlm.nih.gov/pubmed/24069070
http://dx.doi.org/10.7150/jca.7123

Ejemplares similares